Compare · EVH vs SE
EVH vs SE
Side-by-side comparison of Evolent Health Inc (EVH) and Sea Limited (SE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVH and SE operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- SE is the larger of the two at $66.94B, about 96.1x EVH ($696.3M).
- Over the past year, EVH is down 45.7% and SE is down 31.0% - SE leads by 14.8 points.
- EVH has hit the wire 6 times in the past 4 weeks while SE has been quiet.
- SE has more recent analyst coverage (25 ratings vs 20 for EVH).
- Company
- Evolent Health Inc
- Sea Limited
- Price
- $6.18+4.39%
- $109.28-1.30%
- Market cap
- $696.3M
- $66.94B
- 1M return
- +34.93%
- +27.54%
- 1Y return
- -45.74%
- -30.99%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 2017
- News (4w)
- 6
- 0
- Recent ratings
- 20
- 25
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Sea Limited
Sea Limited, together with its subsidiaries, engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally. It provides Garena digital entertainment platform for users to access mobile and PC online games, as well as eSports operations; and access to other entertainment content, such as livestreaming of gameplay and social features, such as user chat and online forums. The company also operates Shopee e-commerce platform, a mobile-centric marketplace that offers integrated payment and logistics infrastructure and seller services. In addition, it offers SeaMoney digital financial services to individuals and businesses, including mobile wallet and payment services AirPay, ShopeePay, SPayLater, and other digital financial services brands; and payment processing services for Shopee. The company was formerly known as Garena Interactive Holding Limited and changed its name to Sea Limited in April 2017. Sea Limited was incorporated in 2009 and is headquartered in Singapore.
Latest EVH
- Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
- Chief Executive Officer Blackley Seth was granted 446,102 shares and covered exercise/tax liability with 10,297 shares, increasing direct ownership by 52% to 1,272,767 units (SEC Form 4) (tax liability)
- General Counsel Weinberg Jonathan was granted 43,055 shares and covered exercise/tax liability with 2,650 shares, increasing direct ownership by 17% to 284,917 units (SEC Form 4) to satisfy tax liability
- PRESIDENT Mccarthy Daniel Joseph was granted 302,585 shares and covered exercise/tax liability with 4,582 shares, increasing direct ownership by 70% to 721,025 units (SEC Form 4) to cover withholding tax
- Chief Accounting Officer Shams Aammaad was granted 28,790 shares, increasing direct ownership by 43% to 95,637 units (SEC Form 4)
- Evolent Health downgraded by Truist with a new price target
- SEC Form S-8 filed by Evolent Health Inc
- Director Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)
- Director Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)
- Director Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)
Latest SE
- NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO
- Sea Limited Reports First Quarter 2026 Results
- Sea Limited to Report First Quarter 2026 Results
- SEC Form 4 filed by Chen Jingye
- SEC Form 4 filed by Ma David Y
- SEC Form 4 filed by Ye Gang
- SEC Form 4 filed by Wang Yanjun
- SEC Form 4 filed by Ma David Y
- SEC Form 4 filed by Ye Gang
- SEC Form 4 filed by Wang Yanjun